Jiangdian Wang

3.0k total citations · 1 hit paper
11 papers, 860 citations indexed

About

Jiangdian Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jiangdian Wang has authored 11 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Surgery. Recurrent topics in Jiangdian Wang's work include Gastric Cancer Management and Outcomes (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Jiangdian Wang is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Jiangdian Wang collaborates with scholars based in United States, South Korea and Japan. Jiangdian Wang's co-authors include Mary J. Savage, Karina Kulangara, Jared Lunceford, Kenneth Emancipator, Jonathan Juco, Debra Hanks, Ellie Corigliano, Nancy R. Zhang, Supriya Shah and Malinka Jansson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Clinical Therapeutics.

In The Last Decade

Jiangdian Wang

11 papers receiving 852 citations

Hit Papers

Clinical Utility of the Combined Positive Score for Progr... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer
    2018 378 citations Karina Kulangara, Nancy R. Zhang et al. Archives of Pathology & Laboratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangdian Wang United States 8 671 409 273 174 142 11 860
Malinka Jansson United States 4 639 1.0× 350 0.9× 170 0.6× 125 0.7× 42 0.3× 11 742
Debra Hanks United States 5 404 0.6× 206 0.5× 155 0.6× 81 0.5× 44 0.3× 10 510
Fabiola Lorena Rojas Llimpe Italy 10 500 0.7× 498 1.2× 217 0.8× 52 0.3× 135 1.0× 32 791
Nathalie Théou–Anton France 14 362 0.5× 322 0.8× 79 0.3× 58 0.3× 80 0.6× 28 666
Sarah Solomon United States 9 199 0.3× 364 0.9× 100 0.4× 71 0.4× 251 1.8× 11 531
Holly Kemberling United States 7 471 0.7× 154 0.4× 125 0.5× 99 0.6× 23 0.2× 9 567
Guanghai Dai China 13 359 0.5× 354 0.9× 183 0.7× 40 0.2× 125 0.9× 34 670
Yasuo Hosouchi Japan 15 221 0.3× 209 0.5× 197 0.7× 50 0.3× 130 0.9× 41 580
Rita P. Dalal United States 10 415 0.6× 311 0.8× 144 0.5× 109 0.6× 103 0.7× 21 622
KIKUO KOUFUJI Japan 14 162 0.2× 358 0.9× 261 1.0× 73 0.4× 123 0.9× 79 657

Countries citing papers authored by Jiangdian Wang

Since Specialization
Citations

This map shows the geographic impact of Jiangdian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangdian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangdian Wang more than expected).

Fields of papers citing papers by Jiangdian Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangdian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangdian Wang. The network helps show where Jiangdian Wang may publish in the future.

Co-authorship network of co-authors of Jiangdian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangdian Wang. A scholar is included among the top collaborators of Jiangdian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangdian Wang. Jiangdian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Haiyan, Zhenhua Yang, Shuang Zhang, et al.. (2020). <p>A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants</p>. Clinical Pharmacology Advances and Applications. Volume 12. 1–11. 3 indexed citations
2.
3.
Kulangara, Karina, Nancy R. Zhang, Ellie Corigliano, et al.. (2018). Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer. Archives of Pathology & Laboratory Medicine. 143(3). 330–337. 378 indexed citations breakdown →
4.
Chung, Hyun Cheol, Jan H.M. Schellens, Jean‐Pierre Delord, et al.. (2018). Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE-158 study.. Journal of Clinical Oncology. 36(15_suppl). 5522–5522. 62 indexed citations
5.
Kulangara, Karina, Scott Boyer, Debra Hanks, et al.. (2018). Investigation of PD-L1 expression and response to pembrolizumab (pembro) in gastric cancer (GC) and cervical cancer (CC) using combined positive score (CPS) and tumor proportion score (TPS).. Journal of Clinical Oncology. 36(15_suppl). 4065–4065. 11 indexed citations
6.
Wainberg, Zev A., Marcelo Garrido, Yung‐Jue Bang, et al.. (2017). KEYNOTE-059 cohort 3: safety and efficacy of pembrolizumab monotherapy for first-line treatment of patients (pts) with PD-L1-positive advanced gastric/gastroesophageal (G/GEJ) cancer. Annals of Oncology. 28. iii153–iii153. 19 indexed citations
7.
Fuchs, Charles S., Toshihiko Doi, Raymond Woo-Jun Jang, et al.. (2017). KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer.. Journal of Clinical Oncology. 35(15_suppl). 4003–4003. 127 indexed citations
8.
Bang, Yung‐Jue, Kei Muro, Charles S. Fuchs, et al.. (2017). KEYNOTE-059 cohort 2: Safety and efficacy of pembrolizumab (pembro) plus 5-fluorouracil (5-FU) and cisplatin for first-line (1L) treatment of advanced gastric cancer.. Journal of Clinical Oncology. 35(15_suppl). 4012–4012. 52 indexed citations
9.
Zhang, Sai, et al.. (2016). Constructing Structure Ensembles of Intrinsically Disordered Proteins from Chemical Shift Data. Journal of Computational Biology. 23(5). 300–310. 9 indexed citations
10.
Xu, Hongrong, Guoqin Wang, Jiangdian Wang, et al.. (2014). Pharmacokinetic Interaction of Finasteride With Tamsulosin Hydrochloride: An Open-label, Randomized, 3-period Crossover Study in Healthy Chinese Male Volunteers. Clinical Therapeutics. 37(2). 462–472. 7 indexed citations
11.
Wang, Jiangdian & Sujit K. Ghosh. (2012). Shape restricted nonparametric regression based on multivariate Bernstein polynomials. NCSU Libraries Repository (North Carolina State University Libraries). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malinka Jansson Breakdown of academic impact, for papers by Debra Hanks Breakdown of academic impact, for papers by Fabiola Lorena Rojas Llimpe Breakdown of academic impact, for papers by Nathalie Théou–Anton Breakdown of academic impact, for papers by Sarah Solomon Breakdown of academic impact, for papers by Holly Kemberling Breakdown of academic impact, for papers by Guanghai Dai Breakdown of academic impact, for papers by Yasuo Hosouchi Breakdown of academic impact, for papers by Rita P. Dalal Breakdown of academic impact, for papers by KIKUO KOUFUJI
Rankless by CCL
2026